PREVENTION AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) BY ANTAGONISM OF THE RECEPTOR TO GLUCOSEDEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP)

Details for Australian Patent Application No. 2003248676 (hide)

Owner ENTEROMED, INC.

Inventors BOYLAN, Michael, O.; WOLFE, Michael, M.

Pub. Number AU-A-2003248676

PCT Number PCT/US03/18554

PCT Pub. Number WO2003/105760

Priority 60/389,320 15.06.02 US; 60/389,320 15.06.02 US

Filing date 13 June 2003

Wipo publication date 31 December 2003

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 60/389,320 15.06.02 US; 60/389,320 15.06.02 US

26 February 2004 Application Open to Public Inspection

  Published as AU-A-2003248676

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003248677-DEVICE FOR LAWFUL INTERCEPT OF INTERNET COMMUNICATIONS

2003248675-GAMING SYSTEM AND METHOD